Dow University Of Health Sciences
Karachi, 74800, Pakistan
NCT Number: NCT03881813
The study evaluates effectiveness of two types of fixed retainers in post orthodontic patients. Half of the subjects are randomly allocated Group 1 retainer (FRC) and other half is given Group 2 retainer (MSW) and followed for a period of one year.
Looking for future studies?
Notify Me14 year–30 year
All sexes
Interventional
Not applicable
Karachi, 74800, Pakistan
54 subjects were recruited and divided into two groups by random allocation. Consents were obtained . Group 1 received fiber reinforced composite retainer and group 2 received multistranded stainless steel wire retainer. The patients were recalled at every three months interval for a period of 12 months. They were evaluated for number of fractures, failure pattern based on adhesive remnant index and relapse tendency by measuring little's irregularity index.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Orthodontic retainers were bonded on the lower teeth of the subjects after fixed orthodontic treatment and were evaluated for their effectiveness for the followup of one year.
Time frame: 12 months
It was measured using Little's irregularity index
Time frame: 12 months
Number of bond failure was assessed at each visit.
Time frame: 12 months
Type of failure pattern was assessed based on Adhesive remnant index.
Dow University of Health Sciences
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05927558
B-cell Non Hodgkin Lymphoma, Disease Attributes
Milan, Italy
View Trial DetailsNCT07552623
Chemically-Induced Disorders, Disease Attributes
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT03029338
Disease Attributes, Hemic and Lymphatic Diseases
Tianjin, China
View Trial DetailsNCT04139434
AML/MDS, CMML
Ann Arbor, Michigan, United States
View Trial Details